Press Releases

and/or
567 News Releases found
Damon Reed
Damon Reed Named Division Head of Pediatric Solid Tumors and Chief of Pediatric Sarcoma Service at Memorial Sloan Kettering Cancer Center

Damon Reed, MD, has joined Memorial Sloan Kettering Cancer Center (MSK) as the inaugural Head of the Division of Pediatric Solid Tumors and as Chief of the Pediatric Sarcoma Service. Dr. Reed is a distinguished oncologist who has dedicated his career to cancer care for children, adolescents, and young adults. A gifted clinician-investigator, he is known for his work in advancing sarcoma clinical research.
a nurse and a patient
Memorial Sloan Kettering Cancer Center Ranked the Best Cancer Center in the Northeast and First in the Nation for Urology Care by U.S. News & World Report

Memorial Sloan Kettering Cancer Center (MSK) has been recognized as the best cancer center in the northeast, the number two hospital for cancer care in the nation, and the number one hospital nationally for urology care by U.S. News & World Report in its annual Best Hospitals listing.
Memorial Sloan Kettering Cancer Center Statement on Affirmative Action

“The recent ruling by the Supreme Court in the cases of Students for Fair Admissions Inc. v. President and Fellows of Harvard College and Students for ...
Shelly Anderson, MPM
Shelly Anderson Named Memorial Sloan Kettering Cancer Center’s Inaugural Hospital President

Memorial Sloan Kettering Cancer Center (MSK) today announced that Shelly Anderson, MPM, will join the institution as the inaugural Hospital President on September 25. Anderson joins MSK from Brigham and Women’s Hospital (BWH) in Boston, where she has been a member of the executive leadership team since 2011, most recently serving as Executive Vice President and Chief Operating Officer.
MSK Awards & Appointments January 2023
MSK Awards & Appointments June 2023

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.
Deb Schrag
ASCO 2023: New Research from Memorial Sloan Kettering Cancer Center and Dana-Farber Brigham Cancer Center Finds that Radiation Can Be Safely Omitted in Select Patients with Locally Advanced Rectal Cancer

Deb Schrag, MD, MPH, gastrointestinal oncologist and Chair of the Department of Medicine, presented results from a randomized phase III trial of neoadjuvant chemoradiation versus neoadjuvant FOLFOX chemotherapy with selective use of chemoradiation, followed by total surgical excision for the treatment of patients with locally advanced rectal cancer.
Ingo Mellinghoff
ASCO 2023: New Research from Memorial Sloan Kettering Cancer Center Identifies Significant Treatment Advancement for Brain Tumors

Ingo K. Mellinghoff, MD, FACP, neuro-oncologist and Chair of the Department of Neurology, presented significant results from a phase III trial in patients with residual or recurrent grade 2 glioma with an IDH1/2 mutation.
MSK Awards & Appointments January 2023
MSK Awards & Appointments May 2023

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.
MSK researchers presenting new research at ASCO 2023, include Carol Aghajanian, MD; Ingo K. Mellinghoff, MD, FACP; and Deb Schrag, MD, MPH
ASCO 2023: Memorial Sloan Kettering Cancer Center Experts to Present Leading Edge Research at the American Society of Clinical Oncology Annual Meeting

Physicians and scientists from Memorial Sloan Kettering Cancer Center (MSK) will join oncology experts and members of the global cancer research community to present the latest advances in cancer during the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, June 2–6 in Chicago.
Marie-Josée and Henry R. Kravis
Memorial Sloan Kettering Cancer Center Announces $40M Gift To Establish The Marie-Josée Kravis Center for Cancer Immunobiology To Advance Immunotherapy Research

The Marie-Josée Kravis Center for Cancer Immunobiology (CCI), made possible by a generous $40 million gift from Henry R. Kravis to honor the visionary leadership of his wife, Marie-Josée Kravis, will establish a strategic research infrastructure that will seamlessly unite MSK scientists and physicians to further accelerate immunotherapy treatments for people with cancer.